阿托伐他汀联合丹红注射液治疗椎-基底动脉硬化致脑供血不足的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the effect of Atorvastatin combined with Danhong Injection in the treatment of cerebral insufficiency caused by vertebrobasilar arteriosclerosis. Methods A retrospective study was conducted in 106 patients with vertebrobasilar arteriosclerosis insufficiency treated in our hospital from June 2018 to October 2019. The patients were divided into control group and study group according to different treatment methods, among them, 53 patients in the control group were treated with Difenidol Hydrochloride Tablets, and 53 patients in the study group were treated with Atorvastatin combined with Danhong Injection, the maximal blood flow velocity and total adverse reaction rate of right basilar artery and left and right vertebral artery during systole were further analyzed. Results After treatment, the maximal arterial blood flow velocity of the study group was higher than that of the control group, the difference was statistically significant (P＜0.05). The total adverse reaction rate of the study group was lower than that of the control group, and the total effective rate of the study group was 94.34%, higher than that of the control group(66.02%), the differences were statistically significant (P＜0.05). Conclusion The effect of Atorvastatin combined with Danhong Injection in the treatment of vertebrobasilar arteriosclerosis insufficiency is ideal, it can obviously improve the clinical symptoms such as visual acuity, dizziness, etc. , it is worth popularizing in clinic.

Key words： Atorvastatin Danhong Injection Vertebrobasilar Arteriosclerosis Cerebral ischemia

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Hong-yan

Cite this article:

GUO Hong-yan. Effect of Atorvastatin combined with Danhong Injection in the treatment of cerebral insufficiency caused by vertebrobasilar arteriosclerosis[J]. 中国当代医药, 2020, 27(16): 85-87.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I16/85

[1]	刘振国.依达拉奉联合丹红注射液治疗急性脑梗死的疗效观察[J].中国现代医生，2019，57（7）：99-101.
[2]	周莎莎.观察阿托伐他汀联合丹红注射液治疗椎-基底动脉硬化致脑供血不足的临床疗效[J].中国医学创新，2016，13（26）：35-39.
[3]	那丽莎，栗昭生，于龙魅，等.阿托伐他汀联合丹红注射液治疗椎-基底动脉硬化致脑供血不足的效果观察[J].中国当代医药，2016，23（24）：28-30.
[4]	张颖，周明学，李思耐，等.丹红注射液对动脉粥样硬化小鼠主动脉斑块的干预作用及基因组DNA 甲基化水平和甲基化转移酶的影响[J].世界中医药，2017，12（2）：247-250，253.
[5]	林川.用阿托伐他汀钙片和丹红注射液治疗椎-基底动脉硬化所致脑供血不足的效果探析[J].当代医药论丛，2016，14（12）：82-83.
[6]	胡白瑜，李金礼，汪爱云，等.阿托伐他汀联合丹红注射液治疗椎-基底动脉硬化致脑供血不足的效果分析[J].中国医药科学，2015，5（19）：100-102.
[7]	张涛，陈晖，黄家树，等.丹红注射液对冠心病介入治疗后血瘀证患者不良心血管事件的影响[J].中国实验方剂学杂志，2018，24（2）：186-191.
[8]	戴海英.阿托伐他汀联合丹红注射液治疗椎—基底动脉硬化致脑供血不足患者的效果观察[J].临床合理用药杂志，2017，10（35）：38-39.
[9]	贾俊霞.阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的临床观察[J].中国民间疗法，2019，27（3）：72，94.
[10]	魏彤.阿托伐他汀联合丹红注射液治疗椎-基底动脉硬化致脑供血不足的疗效分析[J].中国医药指南，2015，5（36）：175.
[11]	肖新怀，徐米清，方燕龄，等.丹红注射液联合瑞舒伐他汀抗冠状动脉粥样硬化的作用机制研究[J].国际医药卫生导报，2019，25（20）：3396-3400.
[12]	余金玉，李秀琪，汪瀚.丹红注射液联合他汀类药物治疗冠状动脉粥样硬化性心脏病的临床效果研究[J].数理医药学杂志，2016，29（11）：1661-1662.
[13]	曹清松.阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足的疗效观察[J].现代诊断与治疗，2016，27（18）：3373-3374.
[14]	张学峰.阿托伐他汀联合丹红注射液治疗椎基底动脉硬化致脑供血不足临床观察[J].山西中医，2017，33（2）：40，47.
[15]	秦薇.研究丹红注射液对冠脉支架内再狭窄及血栓形成的影响[J].航空航天医学杂志，2018，29（10）：1241-1242.